Founder of Five Prime Therapeutics and COR Therapeutics

Chief Scientific Officer & board member of Chiron Corporation (now Novartis Vaccines and Diagnostics, Inc.)

Professor of medicine, UCSF and director of Cardiovascular Research Institution and Daiichi Research Center. Also served on the faculties of Harvard Medical School and Massachusetts General Hospital

Member of National Academy of Sciences and fellow of the American Academy of Arts and Sciences

B.S. Rice University; M.D./Ph.D. Duke University

Assoc. Prof. of chemistry, The Scripps Research Institute; Asst. Prof. of internal medicine, UT Southwestern Medical Center

Published and patented > 50 papers on novel small molecule and peptoid-based drug discovery

Inventor of the Ten30’s large-scale library synthesis & screening platform

PhD from Indian Institute of Chemical Technology 

Director of Biological Nanostructures, Lawrence Berkeley National Lab http://www.ronznet.com

Inventor of a new class of heteropolymers called "Peptoids“ in early 1990’s

A founding chemist at Protos Corp. (drug discovery venture)

PhD from UC Berkeley in Bioorganic Chemistry with Dr. Peter Schultz; published >170 papers, 38 patents

Faculty of Stanford University and Haas School of Business, UC Berkeley

30+ years of VC management and start-ups in advanced technologies

Commercialization expert at Lawrence Berkeley National Lab

MBA from Stanford University; MS in Chemical Engineering

Professor of Radiology and Biomedical Engineering, Medicine, Psychiatry and Neurobiology at the University of California, San Francisco

Principle Investigator of Alzheimer's Disease Neuroimaging Initiative (ADNI), the largest observational study in the world for Alzheimer’s disease

Director, Center for Imaging of Neurodegenerative Diseases, UCSF VA Medical Center, San Francisco, California

Published >900 articles and 70 book chapters. Link: http://profiles.ucsf.edu/michael.weiner

B.S. Johns Hopkins University; M.D. SUNY Medical Center; Fellowship at Yale University School of Medicine

David G. Nathan Distinguished Professor of Pediatrics and Chairman of the Department of Pediatric Oncology at Harvard Medical School

Member of the National Academy of Sciences and Investigator Howard Hughes Medical Institute

Featured stories and articles:

• Time Magazine’s “100 Most Influential People of 2024” 

• CRISPR gets the glory in landmark approval  - article in the nature reviews drug discovery

• In Our Blood: A Profile of Stuart Orkin - article in The New Scientist

• At 16, she's a pioneer in the fight against blood disease - article in the New York Times

• Approval of First ‘Epigenetic’ Drug for a Solid Tumor is Milestone

Professor of Chemical Biology and Molecular Therapeutics, Department of Molecular and Cell Biology (Division of Molecular Therapeutics), University of California, Berkeley

Director of the Novartis-Berkeley Translational Chemical Biology Institute, University of California, Berkeley

Founder of Vicinitas Therapeutics, Co-Founder of Frontier Medicines, and co-founder of Zenith

PhD from UC Berkeley in Molecular Toxicology